CBD Life Sciences Inc. (CBDL)
Targets Alibaba as the Next Retail Giant for Wholesale Expansion of
Top-Selling CBD Products
Leveraging Alibaba's 1.28 billion
annual active consumers and $3 trillion in gross merchandise volume
to accelerate growth and global market penetration.
SCOTTSDALE, AZ --
October 10, 2024 -- InvestorsHub NewsWire -- CBD Life Sciences Inc. (OTC:
CBDL), a trailblazer in the CBD industry, proudly announces a
bold new step in its expansion strategy by targeting Alibaba, the world's largest retail and
e-commerce platform. With an eye on global dominance, CBDL is set
to offer its top-selling CBD products to Alibaba's vast wholesale
marketplace, unlocking access to over 1.28 billion annual active consumers
and an astounding $3 trillion in
gross merchandise volume (GMV). This move marks a
significant milestone in CBD Life Sciences' rapid ascent and
positions the company for exponential revenue growth and global
market penetration.
"Our entrance into
Alibaba is more than just an expansion—it's a game-changer," said
Lisa Nelson, President & CEO of CBD Life Sciences Inc.
"Alibaba's platform opens up access to markets we've only just
begun to explore, and this leap forward will not only drive our
revenue to new heights but will strengthen our relationship with
valued shareholders, who are the backbone of our success."
Massive Opportunity: Alibaba's Wholesale
Powerhouse
Alibaba is the
world's top e-commerce platform, facilitating over $172 billion in cross-border commerce
annually. For CBD Life Sciences, this presents a massive
opportunity to capitalize on the growing demand for high-quality
CBD products in regions where CBD is rapidly gaining popularity.
CBDL's flagship products—ranging from nano CBD coffee creamers and
pain relief creams—will
now be available to wholesalers across Asia, Europe, and
beyond.
By tapping into
Alibaba's extensive network of buyers, CBD Life Sciences is
positioning itself as a leading supplier of CBD products to
retailers around the globe. This expansion is expected to amplify
both domestic and international sales, contributing to the already
1405.46% revenue increase
the company has experienced since February 2024.
Unstoppable Growth and Shareholder
Confidence
Since early 2024,
CBD Life Sciences has maintained an impressive upward trajectory,
breaking records quarter after quarter. Shareholders have witnessed
the company's evolution from a pioneering CBD startup to an
industry leader with a diverse product line that caters to a
growing market of health-conscious consumers. This expansion into
Alibaba ensures that CBDL will not only maintain but accelerate
this momentum.
As the global CBD
market continues to surge—expected to exceed $47 billion by 2028—CBD Life Sciences
is at the forefront, making decisive moves to capitalize on this
trend. The entry into Alibaba represents a significant milestone,
one that promises to multiply revenues and shareholder value in the
coming quarters.
"With our entrance
into Alibaba, we're taking the brand global at a scale we've never
seen before. Our loyal shareholders are at the heart of this
growth, and their support allows us to keep pushing boundaries,
explore new opportunities, and bring cutting-edge products to
consumers worldwide," added Nelson. "Together, we will conquer new
markets and achieve new heights."
Looking Ahead: Unwavering Commitment to
Innovation and Expansion
CBD Life Sciences
Inc. remains committed to providing best-in-class CBD products,
with a portfolio ranging from water-soluble nano CBD formulations to
CBD pain relief solutions
that continue to set industry standards. The company is also
focused on future innovations, with new product launches expected
in the upcoming quarters, all designed to deliver unrivaled quality
and efficacy.
By leveraging
Alibaba's vast wholesale distribution channels, CBD Life Sciences
is laying the groundwork for long-term growth and sustainability.
Shareholders can expect sustained success, as the company continues
to execute on its aggressive global expansion strategy. Every step
forward is an opportunity to deliver value and drive substantial
returns for those who have invested in the company's vision.
About CBD Life Sciences Inc.
CBD Life Sciences
Inc. (OTC:
CBDL) is a leader in the CBD sector, specializing in
innovative, high-quality products that utilize cutting-edge
nanotechnology for superior bioavailability and maximum health
benefits. With a broad portfolio of products, from pain creams to
consumables, CBDL is committed to enhancing the lives of its
consumers. The company is on a fast-paced trajectory to expand its
global presence through retail and wholesale channels, both online
and in brick-and-mortar stores.
Follow our social media for the latest
updates!
X: https://www.x.com/CBDL_StockOTC
Instagram: https://www.instagram.com/cbd.vault
IR Contact: cbdvaultaz@gmail.com
Forward-Looking Statements
Except for the
historical information contained herein, the matters discussed in
this press release are forward-looking statements. Actual results
may differ materially from those described in forward-looking
statements and are subject to risks and uncertainties. See CBD Life
Sciences, Inc's, Inc.'s filings with OTC Markets, which may
identify specific factors that may cause actual results or events
to differ materially from those described in the forward-looking
statements.
Safe Harbor Statement
This release
includes forward-looking statements, which are based on certain
assumptions and reflects management's current expectations. These
forward-looking statements are subject to a number of risks and
uncertainties that could cause actual results or events to differ
materially from current expectations. Some of these factors
include: general global economic conditions; general industry and
market conditions, sector changes and growth rates; uncertainty as
to whether our strategies and business plans will yield the
expected benefits; increasing competition; availability and cost of
capital; the ability to identify and develop and achieve commercial
success; the level of expenditures necessary to maintain and
improve the quality of services; changes in the economy; changes in
laws and regulations, including codes and standards, intellectual
property rights, and tax matters; or other matters not anticipated;
our ability to secure and maintain strategic relationships and
distribution agreements. The Company disclaims any intention or
obligation to update or revise any forward-looking ability to
secure and maintain strategic relationships and distribution
agreements. The Company disclaims any intention or obligation to
update or revise any forward-looking statements.
Contact Information:
Lisa Nelson
CEO
cbdvaultaz@gmail.com
4802091720
